Teva Pharmaceutical (Israel) Investor Sentiment

TEVA Stock  ILA 4,950  30.00  0.60%   
About 62% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. Teva Pharmaceutical's investor sentiment overview provides quick insight into current market opportunities from investing in Teva Pharmaceutical Industries. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Teva Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Teva daily returns and investor perception about the current price of Teva Pharmaceutical Industries as well as its diversification or hedging effects on your existing portfolios.
  
a day ago at news.google.com         
Raymond James Associates Boosts Position in Teva Pharmaceutical Industries Limited - Defense World
Google News at Macroaxis
few days ago at news.google.com         
Teva Pharmaceutical Industries Trading Down 5.3 percent - Defense World
Google News at Macroaxis
over two weeks ago at news.google.com         
Teva and Viatris revives chance to dispute JJs schizophrenia drug patent - Seeking Alpha
Google News at Macroaxis
over two weeks ago at news.google.com         
Schechter Investment Advisors LLC Makes New Investment in Teva Pharmaceutical Industries Limited - D...
Google News at Macroaxis
over two weeks ago at news.google.com         
Short Interest in Teva Pharmaceutical Industries Limited Decreases By 28.9 percent - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
Teva Pharmaceutical Industries Limited Shares Acquired by Wellington Management Group LLP - MarketBe...
Google News at Macroaxis
over three weeks ago at news.google.com         
Institutional investors have a lot riding on Teva Pharmaceutical Industries Limited with 67 percent ...
Google News at Macroaxis
over three weeks ago at news.google.com         
Teva Pharmaceutical Industries Potential Outweighs Concerns - Seeking Alpha
Google News at Macroaxis
over three weeks ago at news.google.com         
American Century Companies Inc. Has 14.77 Million Holdings in Teva Pharmaceutical Industries Limited...
Google News at Macroaxis
over three weeks ago at news.google.com         
Teva Pharmaceutical Industries Sets New 12-Month High at 13.93 - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Insights Into the Generic Drugs Market in Canada, 2024-2032, Featuring Apotex, Mylan Pharmaceuticals...
Google News at Macroaxis
over three weeks ago at news.google.com         
Premarket Mover Teva Pharmaceutical Industries Ltd Down 0.60 percent - InvestorsObserver
Google News at Macroaxis
over three weeks ago at news.google.com         
Teva Pharmaceutical Industries Limited Shares Sold by Deutsche Bank AG - Defense World
Google News at Macroaxis
over a month ago at news.google.com         
Teva Pharmaceutical Industries Limited Stock Holdings Lifted by Public Sector Pension Investment Boa...
Google News at Macroaxis
over a month ago at news.google.com         
Legal General Group Plc Has 35.71 Million Holdings in Teva Pharmaceutical Industries Limited - Defen...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
Check out Teva Pharmaceutical Hype Analysis, Teva Pharmaceutical Correlation and Teva Pharmaceutical Performance.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Please note, there is a significant difference between Teva Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.